• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 71
  • 21
  • 17
  • 16
  • 7
  • 2
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 161
  • 42
  • 37
  • 35
  • 23
  • 22
  • 21
  • 19
  • 18
  • 16
  • 15
  • 15
  • 15
  • 13
  • 13
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
121

Optimizing harvesting for facial lipografting with a new photochemical stimulation concept: One STEP technique™

Centurión, Patricio, Gamarra, Ronald, Caballero, Gonzalo, Kaufmann, Paul, Delgado, Pia 01 December 2020 (has links)
Background: Facial fat grafting for rejuvenation is one of the most popular facial aesthetic procedures in plastic surgery. It is always challenging and since there are a lot of techniques for adipose tissue (AT) harvesting, there are no standard procedures that guarantee natural and long-lasting results. We developed the selective tissue engineering photo stimulation technique (One STEP™) in which we used a novel infrared 1210-nm wavelength laser diode for fat preserved harvesting and direct fat injection that we named PicoGraft™, with no fat manipulation. Methods: This is a retrospective descriptive study in which we included all senior author’s patients that got facial fat grafting using the One STEP™ technique. We compared the AT aspirated, after laser emission (STEP-PicoGraft) and the standard assisted liposuction samples (SAL) in cultures. We study the mitochondrial activity of the ASC between STEP and SAL in fresh samples and after 24 h. The evaluation of the results included subjective changes regarding wrinkles, grooves, palpebral bags, hyperchromic spots, and fat hypotrophy of our patients. Results: Between July 2013 and May 2018, a total of 245 patients underwent facial fat grafting using this novel technique. We observed adipocytes preserved after STEP harvesting comparing morphologic changes in SAL samples with a high concentration of inflammatory particles in cultures. ASC mitochondrial activity shows an important difference of more than 7 times in STEP samples in fresh analysis that increase 12 times in 24 h. The subjective results show a good improvement in the periorbital area. The changes on the skin and subcutaneous tissue are seen from the second month and continue to improve up to 12 months. Conclusions: Facial fat grafting using the PicoGraft™ obtained by One STEP™ technique gives excellent volumetric and regenerative results in a single treatment without volumetric hypercorrection, and it is a good alternative for facial rejuvenation. The fat graft obtained with this novel technique is homogenous, without lumps, and has high concentration of viable stimulated ADSC and a high number of viable adipocytes. Level of evidence: Level III, therapeutic study. / Revisión por pares
122

Hypothalamic brain-derived neurotrophic factor regulates lymphocyte immunity, energy balance, and cancer progression

Bergin, Stephen Michael 26 May 2017 (has links)
No description available.
123

Effects of Whole-Body Adenylyl Cyclase 5 (Adcy5) Deficiency on Systemic Insulin Sensitivity and Adipose Tissue

Dommel, Sebastian, Hoffmann, Anne, Berger, Claudia, Kern, Matthias, Klöting, Nora, Kannt, Aimo, Blüher, Matthias 30 January 2024 (has links)
Genome-wide association studies have identified adenylyl cyclase type 5 (ADCY5) as candidate gene for diabetes-related quantitative traits and an increased risk of type 2 diabetes. Mice with a whole-body deletion of Adcy5 (Adcy5–/–) do not develop obesity, glucose intolerance and insulin resistance, have improved cardiac function and increased longevity. Here, we investigated Adcy5 knockout mice (Adcy5–/–) to test the hypothesis that changes in adipose tissue (AT) may contribute to the reported healthier phenotype. In contrast to previous reports, we found that deletion of Adcy5 did not confer any physiological or biochemical benefits. However, this unexpected finding allowed us to investigate the effects of Adcy5 depletion on AT independently of lower body weight and a metabolically healthier phenotype. Adcy5–/– mice exhibited an increased number of smaller adipocytes, lower mean adipocyte size and a distinct AT gene expression pattern with midline 1 (Mid1) as the most significantly downregulated gene compared to control mice. Our Adcy5–/– model challenges previously described beneficial effects of Adcy5 deficiency and suggests that targeting Adcy5 does not improve insulin sensitivity and may therefore limit the relevance of ADCY5 as potential drug target.
124

Role of DKK-1 in bone fragility and miRNA crosstalk in T1D

Daamouch, Souad 20 February 2024 (has links)
My PhD dissertation reports my research investigations performed on bone loss projects. 2 projects are described in this thesis. One project dealing with the effect of adipogenic DKK1 on bone loss under normal and under a high-fat-diet (HFD). The 2nd projects aimed to investigate on the potential of miRNAs to be used as potential biomarkers to predict bone fragility in T1D.
125

Proteomic studies on protein N-terminus and peptide ion mobility by nano-scale liquid chromatography/tandem mass spectrometry / ナノスケール液体クロマトグラフィー/タンデム質量分析によるタンパク質N末端およびペプチドイオンモビリティーに関するプロテオミクス研究

Chang, Chih-Hsiang 23 March 2021 (has links)
京都大学 / 新制・課程博士 / 博士(薬科学) / 甲第23135号 / 薬科博第134号 / 新制||薬科||15(附属図書館) / 京都大学大学院薬学研究科薬科学専攻 / (主査)教授 石濱 泰, 教授 松﨑 勝巳, 教授 加藤 博章 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM
126

Studies on the effects of regulators of the cholesterol biosynthesis pathway and fatty acid oxidation on the thermogenic adipocyte function / コレステロール生合成経路及び脂肪酸酸化の調節因子による脂肪細胞の熱産生機能制御機構に関する研究

Kwon, Jungin 25 March 2024 (has links)
京都大学 / 新制・課程博士 / 博士(農学) / 甲第25356号 / 農博第2622号 / 京都大学大学院農学研究科食品生物科学専攻 / (主査)教授 井上 和生, 教授 佐々木 努, 准教授 後藤 剛 / 学位規則第4条第1項該当 / Doctor of Philosophy (Engineering) / Kyoto University / DFAM
127

Differential Expression of Surface Markers in Mouse Bone Marrow Mesenchymal Stromal Cell Subpopulations with Distinct Lineage Commitment

Anastassiadis, Konstantinos, Rostovskaya, Maria 18 January 2016 (has links) (PDF)
Bone marrow mesenchymal stromal cells (BM MSCs) represent a heterogeneous population of progenitors with potential for generation of skeletal tissues. However the identity of BM MSC subpopulations is poorly defined mainly due to the absence of specific markers allowing in situ localization of those cells and isolation of pure cell types. Here, we aimed at characterization of surface markers in mouse BM MSCs and in their subsets with distinct differentiation potential. Using conditionally immortalized BM MSCs we performed a screening with 176 antibodies and high-throughput flow cytometry, and found 33 markers expressed in MSCs, and among them 3 were novel for MSCs and 13 have not been reported for MSCs from mice. Furthermore, we obtained clonally derived MSC subpopulations and identified bipotential progenitors capable for osteo- and adipogenic differentiation, as well as monopotential osteogenic and adipogenic clones, and thus confirmed heterogeneity of MSCs. We found that expression of CD200 was characteristic for the clones with osteogenic potential, whereas SSEA4 marked adipogenic progenitors lacking osteogenic capacity, and CD140a was expressed in adipogenic cells independently of their efficiency for osteogenesis. We confirmed our observations in cell sorting experiments and further investigated the expression of those markers during the course of differentiation. Thus, our findings provide to our knowledge the most comprehensive characterization of surface antigens expression in mouse BM MSCs to date, and suggest CD200, SSEA4 and CD140a as markers differentially expressed in distinct types of MSC progenitors.
128

Function of Fra1 in mesenchymal stromal cell differentiation & the potential immune modulatory role of Fra1

Drießler, Frank 06 August 2008 (has links)
Aktivator Protein-1 (AP-1) ist ein kollektiver Terminus für dimerische Transkriptionsfaktoren, die sich aus Fos- und Jun- Proteinen zusammensetzen. Diese Untereinheiten binden an eine gemeinsame, spezifische DNA-Sequenz, die AP-1 Bindungsstelle. Zusätzlich zu der gut dokumentierten Rolle des c-Fos Proteins in der Tumorgenese, wo dieses Gen als ein Aktivator beschrieben ist, übt AP-1 einen Einfluss auf mesenchymale Stromazellen und Immunzellen aus. Mesenchymale Knochenmarkszellen sind die Vorläuferzellen für Adipozyten, Osteoblasten, Chondrozyten, Myozyten und Fibroblasten. Die molekularen Mechanismen, welche die Differenzierungen regeln, sind noch weitgehend unerforscht. Der heterodimere Transkriptionsfaktor AP-1 übt eine wichtige Rolle in der Kontrolle der Zelldifferenzierung aus. Verschieden genetisch veränderte Mausmodelle untermauerten dies. Mäuse, welche das Fos-related antigen-1 (Fra1) oder eine kürzere Protein-Isoform von FosB (deltaFosB) überexpremieren, entwickelten, durch eine beschleunigte Differenzierung der Osteoblasten, eine Osteosklerose. Interessanterweise konnte gezeigt werden, dass die transgenen deltaFosB Mäuse weniger Fett haben. Die Stabilität und Aktivität von Fos Proteinen kann durch post-transkriptionale Modifizierungen geregelt werden. Basierend auf knockout Mausmodellen, wurde eine tragende Rolle für das wachstumsregulierende Enzym Rsk2 postuliert. Rsk2 spielt eine mögliche Rolle bei der Ausdifferenzierung von mesenchymalen Vorläuferzellen zu Osteoblasten und Adipozyten. Das Ziel dieser Arbeit war es molekulare Mechanismen zu finden, welche die unterschiedlichen Phänotypen (wild typ, fra1-tg, rsk2-defizient und fra1-tg/rsk2-defizient) charakterisieren. Die Knochenuntersuchungen der verschiedenen Genotypen zeigten, dass Fra1 und Rsk2, unabhängig voneinander, tragende Rollen im Knochenmetabolismus spielen. Quantitative Analysen von Adipozytenmarker, wie PPARgamma und C/EBPalpha zeigten, dass das Protein Fra1 die Adipozytenreifung in vivo und in vitro reguliert. Zusätzlich entwickelten die „doppel-mutierten“ fra1-tg/rsk2-/y Mäuse einen Lipodystrophy. Ein milderer Phänotyp wurde in den fra1-tg Tieren beobachtet, jedoch nicht in den Rsk2-knockout Mäusen. Zusätzlich wurde beobachtet, dass mesenchymale Zellen, welche Fra1 überexprimieren, gegen Glucocorticoid-induzierte Wachstumshemmung resistent waren. Diese Wirkung kann am wahrscheinlichsten durch die Fra1-vermittelte Suppression des Glucocorticoidrezeptors erklärt werden. Außerdem beeinflusste die Überexpression von Fra1 die Milzentwicklung. Leber und Herzanalysen zeigten, dass Fra1 kollagenhaltiges Gewebe induziert. Krankheiten wie Cholangitis und Fibrosen waren die Folge. / AP-1 transcription factor is a general name for multiple dimers formed by the association of Fos (or ATF) and Jun proteins. AP-1 acts as a sensor of changes in the cellular environment and thus, it is implicated in the modulation of cell proliferation, differentiation, transformation and cell death. Besides the well-documented role of c-Fos protein in oncogenesis, where this gene can function as a tumor promoter, AP-1 proteins are being recognized as regulators for mesenchymal stromal cell development and as regulators of immune cells. The mesenchymal stromal cells are the common progenitors for various mesenchymal lineages such as adipocytes, osteoblasts, chondrocytes, myocytes and fibroblasts. AP-1 seems to play a key role in the control of mesenchymal cell fate decision and differentiation. This is suggested by phenotypes of mice with a genetic modifications in either the Jun or the Fos component of AP-1. In particular, mice overexpressing the Fos-related antigen-1 (Fra1) or the short isoform of FosB (deltaFosB) have been found to develop osteosclerosis due to an accelerated differentiation of osteoblasts. Interestingly, mice overexpressing deltaFosB also developed less fat tissue. The activity of Fos proteins can be regulated by post-transcriptional modification. Based on knockout mouse model, a role for the growth factor regulated kinase Rsk2 was proposed in the differentiation of mesenchymal stromal cells to osteoblasts as well as in fat tissue development. Goal in this study was to identify the molecular mechanisms explaining the differences between the wild type, fra1-tg, rsk2-deficient and fra1-tg/rsk2-deficient phenotypes. The comparison of the bones of the different mice genotypes revealed, that Fra1 and Rsk2 were independently regulating bone metabolism. Quantitative analysis of adipocyte markers expressions, like PPARgamma and C/EBPalpha revealed, that Fra1 overexpression was blocking adipocyte maturation in vivo and in vitro. Moreover, the in vivo results show that the fra1-tg/rsk2-/y mice develop a severe lipodystrophy. A milder phenotype was observed in the parental fra1-tg strain but not in the Rsk2 knockout strain. Additionally, it was been observed, that mesenchymal cells overexpressing Fra1 were resistant to glucocorticoid-induced growth inhibition. This effect can most likely be explained by Fra1-mediated downregulation of the glucocorticoid receptor. Furthermore, Fra1 overexpression influenced spleen development. Liver and heart analyses showed that Fra1 overexpression induced collagen tissue. Diseases like cholangitis and fibrosis were the outcome.
129

Localização e tráfego subcelular de aminopeptidases em adipócitos de ratos obesos e privados de alimento / Subcelular localization and trafficking of aminopeptidases in adipocytes of obese and food deprived rats

Vendrame, Rafaela Fadoni Alponti 03 April 2013 (has links)
A descoberta de aminopeptidase regulada por insulina (IRAP), a qual hidrolisa peptídeos como ocitocina e vasopressina e é receptora de angiotensina IV, destaca a importância do estudo do envolvimento de peptidases na função endócrina do adipócito. Estudos recentes detectaram alterações das atividades de aminopeptidase neutra e de dipeptidil peptidase IV (DPPIV) no plasma e no hipotálamo e hipocampo na obesidade induzida por glutamato monossódico (MSG). A presente tese propôs (i) a existência de atividades aminopeptidásicas ácida (APA), básica (APB), neutra insensível (APM) e sensível à puromicina (PSA), metionil (MetAP) e DPPIV, além da já conhecida (leucil (LAP)/cistil (CAP)/IRAP), nas frações de membrana plasmática (FM) e de alta (HDM) e baixa (LDM) densidade microssomal de adipócitos isolados do depósito de gordura retroperitoneal; (ii) que suas atividades catalíticas, expressões gênicas e tráfego subcelular seriam diferenciados entre obesos induzidos por MSG, submetidos ou não à privação alimentar e em animais controle sadios, submetidos ou não a privação alimentar; (iii) e influenciadas por insulina, angiotensina II, angiotensina IV e vasopressina. A existência de todas essas aminopeptidases no adipócito foi demonstrada, sendo a APM a que apresenta maior Vmax e maior eficiência catalítica e a APA a maior afinidade. Os animais obesos apresentaram aumento do diâmetro médio dos adipócitos e aumento do lipócrito, caracterizando hipertrofia adipocítica, enquanto os controles privados de alimento tiveram um aumento no número de adipócitos e aumento no lipócrito, caracterizando hiperplasia adipocítica. Pela primeira vez, um perfil variado de atividades aminopeptidásicas distribuídas em diferentes compartimentos subcelulares do adipócito é evidenciado juntamente com a demonstração de diferenças no padrão de distribuição destas atividades entre os ratos obesos e sadios, privados ou não de alimento. Dentre as novas aminopeptidases detectadas no adipócito não há nenhuma com a característica clássica de IRAP. No geral, as alterações das atividades catalíticas nas diferentes situações sob estudo mostram o envolvimento dessas novas aminopeptidases na regulação endócrina do balanço energético (provavelmente via ação hidrolítica sobre angiotensina II e vasopressina) sob modulação por angiotensina IV (APB, APM, DPPIV, LAP/IRAP, MetAP e PSA em animais controle sadios e APB em animais controle privados de alimento), angiotensina II (APB e PSA nos animais obesos) e vasopressina (APB nos animais obesos privados de alimento; e influenciadas em seu tráfego subcelular por angiotensina II (CAP, DPPIV e LAP/IRAP) e angiotensina IV (LAP/IRAP). O tráfego subcelular da conhecida atividade CAP/IRAP mostrou-se suscetível à insulina e vasopressina / The discovery of insulin-regulated aminopeptidase (IRAP), which hydrolyzes peptides such as oxytocin and vasopressin and is an angiotensin IV receptor, highlights the importance of the involvement of peptidases in the endocrine function of adipocyte. Recent studies have detected changes in aminopeptidase activities of neutral aminopeptidase and dipeptidyl peptidase IV (DPPIV) in the plasma and in the hypothalamus and hippocampus of rats with obesity induced by monosodium glutamate (MSG). The present thesis proposes (i) the existence of acid (APA), basic (APB), neutral insensitive (APM) and puromycin sensitive (PSA) aminopeptidases, methionyl aminopeptidase (MetAP) and dipeptidyl peptidase IV (DPPIV), besides the well-known cystyl (CAP) / leucine aminopeptidase (LAP) / IRAP) in plasma membrane (MF) and in high (HDM) and low (LDM) density microsomes of isolated adipocytes from retroperitoneal fat pad; (ii) that their catalytic activities, gene expression and subcellular trafficking were different among MSG-induced obese and healthy control rats (food deprived or not); (iii) and influenced by insulin, angiotensin II and IV, and vasopressin. The existence of all these adypocite aminopeptidases was demonstrated. APM has a highest Vmax and catalytic efficiency, while APA has a highest substrate affinity. The obese animals have increased mean diameter of adipocytes and lipocrit, characterizing hypertrophy, while the food deprived rats had an increased number of adipocytes and lipocrit, characterizing hyperplasia. For the first time, a profile of varied aminopeptidases activities distributed in different subcellular compartments of adipocyte is evidenced together with the demonstration of differences in the distribution pattern of these activities among the obese and healthy rats, food deprived or not. Among these novel aminopeptidases detected in adipocytes there is no one with the classical characteristic of IRAP. In general, changes on catalytic activities in these different situations show the involvement of these novel aminopeptidases in the endocrine regulation of energy balance (probably via hydrolytic action on angiotensin II and vasopressin) under modulation by angiotensin IV (APB, APM, DPPIV, LAP/IRAP, MetAP and PSA in healthy animals and APB in food deprived healthy animals), by angiotensin II (APB and PSA in obese) and by vasopressin (APB in food deprived obese animais); and under influence of by angiotensin II (CAP, DPPIV, LAP/IRAP) and angiotensin IV (LAP/IRAP) on their subcellular trafficking. Subcellular trafficking of the well-known CAP/IRAP was susceptible to insulin and vasopressin
130

PYOCYANIN, A VIRULENCE FACTOR PRODUCED BY SEPSIS-CAUSING PSEUDOMONAS AERUGINOSA, PROMOTES ADIPOSE WASTING AND CACHEXIA

Larian, Nika 01 January 2019 (has links)
Sepsis is a leading cause of death among critically ill patients that results in metabolic alterations including hypercatabolism, lipoatrophy, and muscle wasting, contributing to the development of cachexia. Septic cachexia is associated with loss of body weight, fat mass, and lean mass and dysregulated immune function. There are currently no efficacious treatment strategies for septic cachexia, and nutritional interventions have limited success in preventing hypercatabolic wasting. Pyocyanin is a virulence factor produced by sepsis-causing Pseudomonas aeruginosa that has been shown to activate the aryl hydrocarbon receptor (AhR), increase inflammation, and produce reactive oxygen species. Thus, pyocyanin represents a novel mechanistic target in the development of septic cachexia. In Aim 1, we hypothesized that pyocyanin reduces adipocyte differentiation and activates AhR in vitro and in vivo. In vitro, pyocyanin reduced differentiation of 3T3-L1 cells to adipocytes and promoted expression of proinflammatory cytokines. These effects were associated with activation of AhR. We established an in vivo model of pyocyanin-induced cachexia using repeat intraperitoneal exposure to pyocyanin in male and female C57BL/6J mice. Acutely, pyocyanin reduced differentiation of stem cells isolated from adipose stromal vascular tissue and augmented expression of proinflammatory cytokines. Chronically, pyocyanin reduced body weight and fat mass, which was associated with adipose-specific AhR activation. Pyocyanin had sexually dimorphic effects on lipolysis and adipocyte inflammation. These data suggest a role of pyocyanin in adipose cachexia associated with sepsis. In Aim 2, we hypothesized that pyocyanin activates adipocyte AhR to promote adipose tissue wasting and cachexia. To test this hypothesis, we used a mouse model of adipocyte-specific deficiency of AhR and chronically administered pyocyanin to male and female mice. In male mice with adipocyte AhR deficiency, effects of pyocyanin to promote adipose wasting and cachexia were attenuated. In contrast, female adipocyte AhR deficient mice had an augmented response to pyocyanin to decrease body weight. Results suggest divergent mechanisms of pyocyanin to regulate adiposity and body weight through adipocyte AhR between male and female mice. These data support a role for pyocyanin in the development of adipose cachexia associated with Pseudomonas aeruginosa sepsis that is partially regulated by adipocyte AhR. Targeting pyocyanin’s effects on adipocytes represents a potentially novel therapeutic approach for septic cachexia that could mitigate septic cachexia, a condition associated with increased risk of mortality in this population.

Page generated in 0.0308 seconds